Mary Keen

661 total citations
38 papers, 503 citations indexed

About

Mary Keen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Mary Keen has authored 38 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in Mary Keen's work include Receptor Mechanisms and Signaling (22 papers), Ion channel regulation and function (8 papers) and Neuroscience and Neuropharmacology Research (5 papers). Mary Keen is often cited by papers focused on Receptor Mechanisms and Signaling (22 papers), Ion channel regulation and function (8 papers) and Neuroscience and Neuropharmacology Research (5 papers). Mary Keen collaborates with scholars based in United Kingdom, Tanzania and United States. Mary Keen's co-authors include John MacDermot, Eamonn Kelly, N.J.M. Birdsall, Edward C. Hulme, Jane M. Stockton, Christopher P. Berrie, Stefan R. Nahorski, Janet E. Merritt, Jennifer A. Hunt and Brian Key and has published in prestigious journals such as Journal of Neurochemistry, Trends in Pharmacological Sciences and European Journal of Biochemistry.

In The Last Decade

Mary Keen

37 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Keen United Kingdom 16 321 179 89 75 44 38 503
K. W. Snowdowne United States 16 503 1.6× 220 1.2× 124 1.4× 30 0.4× 19 0.4× 22 732
R.A. Podevin France 15 392 1.2× 166 0.9× 68 0.8× 32 0.4× 37 0.8× 23 608
R Alvarez United States 8 261 0.8× 78 0.4× 55 0.6× 97 1.3× 24 0.5× 17 369
P.-A. Löschmann Germany 12 294 0.9× 287 1.6× 94 1.1× 95 1.3× 24 0.5× 19 822
G�nter Schultz Germany 14 632 2.0× 297 1.7× 171 1.9× 47 0.6× 49 1.1× 15 869
Jean‐François Coquil France 12 409 1.3× 124 0.7× 102 1.1× 35 0.5× 73 1.7× 23 505
J F Dixon United States 14 379 1.2× 135 0.8× 64 0.7× 34 0.5× 13 0.3× 16 655
Iain G. Dougall United Kingdom 17 528 1.6× 229 1.3× 235 2.6× 118 1.6× 119 2.7× 29 939
Takeshi Matsugi Japan 14 170 0.5× 50 0.3× 83 0.9× 87 1.2× 35 0.8× 25 685
Douglas G. McCartney Canada 13 265 0.8× 84 0.5× 128 1.4× 57 0.8× 15 0.3× 25 405

Countries citing papers authored by Mary Keen

Since Specialization
Citations

This map shows the geographic impact of Mary Keen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Keen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Keen more than expected).

Fields of papers citing papers by Mary Keen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Keen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Keen. The network helps show where Mary Keen may publish in the future.

Co-authorship network of co-authors of Mary Keen

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Keen. A scholar is included among the top collaborators of Mary Keen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Keen. Mary Keen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keen, Mary. (2003). Radioligand-Binding Methods for Membrane Preparations and Intact Cells. Humana Press eBooks. 83. 1–24. 15 indexed citations
2.
Keen, Mary. (2003). The Problems and Pitfalls of Radioligand Binding. Humana Press eBooks. 41. 1–16. 16 indexed citations
3.
Hawtin, Stuart, John Simms, Rosemary A. Parslow, et al.. (2003). An arginyl in the N‐terminus of the V1a vasopressin receptor is part of the conformational switch controlling activation by agonist. European Journal of Biochemistry. 270(23). 4681–4688. 8 indexed citations
4.
Keen, Mary. (1998). Receptor Binding Techniques. Humana Press eBooks. 12 indexed citations
5.
Key, Brian, et al.. (1995). Inhibition of prostacyclin release from cultured endothelial cells by nitrovasodilator drugs. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1269(3). 237–242. 23 indexed citations
6.
Keen, Mary, et al.. (1994). Deep venous thrombosis and the association with burns involving the lower extremities. Archives of Physical Medicine and Rehabilitation. 75(9). 1045. 1 indexed citations
7.
MacDermot, John, et al.. (1994). Desensitization of adenylate cyclase responses following exposure to IP prostanoid receptor agonists. Biochemical Pharmacology. 47(6). 953–959. 19 indexed citations
8.
Keen, Mary, et al.. (1994). The role of protein kinase A and protein kinase C in prostanoid IP receptor desensitization in NG108-15 cells. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1206(2). 203–207. 7 indexed citations
9.
Keen, Mary, Eamonn Kelly, Andrew Austin, et al.. (1992). Cyclic AMP produces desensitization of prostacyclin and adenosine A2 receptors in hybrid cell lines but does not affect Gs function. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1134(2). 157–163. 11 indexed citations
10.
Hunt, Jennifer A., Janet E. Merritt, John MacDermot, & Mary Keen. (1992). Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells. Biochemical Pharmacology. 43(8). 1747–1752. 20 indexed citations
11.
Keen, Mary. (1991). Testing models of agonism for G protein-coupled receptors. Trends in Pharmacological Sciences. 12(10). 371–374. 17 indexed citations
12.
Merritt, Janet E., Trevor J. Hallam, Anthony Brown, et al.. (1991). Octimibate, a potent non‐prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. British Journal of Pharmacology. 102(1). 251–259. 30 indexed citations
13.
Keen, Mary, Eamonn Kelly, & John MacDermot. (1991). Guanine nucleotide sensitivity of [3H]iloprost binding to prostacyclin receptors. European Journal of Pharmacology Molecular Pharmacology. 207(2). 111–117. 13 indexed citations
14.
Merritt, Janet E., Anthony Brown, David G. Cooper, et al.. (1991). Primate vascular responses to octimibate, a non‐prostanoid agonist at the prostacyclin receptor. British Journal of Pharmacology. 102(1). 260–266. 17 indexed citations
15.
Kelly, Eamonn, et al.. (1990). NaF and guanine nucleotides modulate adenylate cyclase activity in NG108‐15 cells by interacting with both Gsand Gi. British Journal of Pharmacology. 100(2). 223–230. 16 indexed citations
16.
Keen, Mary, et al.. (1989). A selective binding site for 3H-NECA that is not an adenosine A2 receptor. Biochemical Pharmacology. 38(21). 3827–3833. 30 indexed citations
17.
Luty, Jason, et al.. (1989). Expression and desensitisation of A2 purinoceptors on cultured bovine aortic endothelial cells. Cardiovascular Research. 23(4). 303–307. 11 indexed citations
18.
19.
20.
Birdsall, N.J.M., Edward C. Hulme, & Mary Keen. (1986). The binding of pirenzepine to digitonin‐solubilized muscarinic acetylcholine receptors from the rat myocardium. British Journal of Pharmacology. 87(2). 307–316. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. W. Snowdowne Breakdown of academic impact, for papers by R.A. Podevin Breakdown of academic impact, for papers by R Alvarez Breakdown of academic impact, for papers by P.-A. Löschmann Breakdown of academic impact, for papers by G�nter Schultz Breakdown of academic impact, for papers by Jean‐François Coquil Breakdown of academic impact, for papers by J F Dixon Breakdown of academic impact, for papers by Iain G. Dougall Breakdown of academic impact, for papers by Takeshi Matsugi Breakdown of academic impact, for papers by Douglas G. McCartney
Rankless by CCL
2026